For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
In the latest session, Acurx Pharmaceuticals Inc (NASDAQ: ACXP) closed at $0.43 down -10.25% from its previous closing price of $0.48. In other words, the price has decreased by -$10.25 from its previous closing price. On the day, 0.84 million shares were traded. ACXP stock price reached its highest trading level at $0.4988 during the session, while it also had its lowest trading level at $0.43.
Ratios:
For a deeper understanding of Acurx Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.93 and its Current Ratio is at 1.93. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 06 ’25 when Scodari Joseph C bought 24,631 shares for $1.01 per share. The transaction valued at 25,000 led to the insider holds 27,708 shares of the business.
Sailer Carl bought 24,631 shares of ACXP for $25,000 on Jan 06 ’25. The Director now owns 137,183 shares after completing the transaction at $1.01 per share. On Jan 06 ’25, another insider, LUCI DAVID P, who serves as the President and CEO of the company, bought 49,261 shares for $1.01 each. As a result, the insider paid 50,000 and bolstered with 1,097,458 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACXP now has a Market Capitalization of 10097088 and an Enterprise Value of 5453203.
Stock Price History:
The Beta on a monthly basis for ACXP is -1.29, which has changed by -0.7990654 over the last 52 weeks, in comparison to a change of 0.12748289 over the same period for the S&P500. Over the past 52 weeks, ACXP has reached a high of $3.33, while it has fallen to a 52-week low of $0.30. The 50-Day Moving Average of the stock is 4.08%, while the 200-Day Moving Average is calculated to be -54.90%.
Shares Statistics:
For the past three months, ACXP has traded an average of 5.98M shares per day and 36780350 over the past ten days. A total of 22.40M shares are outstanding, with a floating share count of 20.39M. Insiders hold about 13.17% of the company’s shares, while institutions hold 14.90% stake in the company. Shares short for ACXP as of 1749772800 were 527341 with a Short Ratio of 0.09, compared to 1747267200 on 383622. Therefore, it implies a Short% of Shares Outstanding of 527341 and a Short% of Float of 2.53.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
Investors are keenly observing as 2.0 analysts analyze and rate the current performance of Acurx Pharmaceuticals Inc (ACXP) in the stock market.The consensus estimate for the next quarter is -$0.12, with high estimates of -$0.11 and low estimates of -$0.12.
Analysts are recommending an EPS of between -$0.45 and -$0.45 for the fiscal current year, implying an average EPS of -$0.45. EPS for the following year is -$0.47, with 2.0 analysts recommending between -$0.39 and -$0.55.
